Liver Metastases in Advanced GU Cancer Predict Poor Response to ICI Therapy
Patients who receive treatment with immune checkpoint inhibitors for advanced renal cell carcinoma and urothelial carcinoma are more likely to experience disease progression and death if they have liver metastases, a study found.